JOLIANT Trademark

Trademark Overview

On Tuesday, July 17, 2012, a trademark application was filed for JOLIANT with the United States Patent and Trademark Office. The USPTO has given the JOLIANT trademark a serial number of 85679294. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 14, 2016. This trademark is owned by Glaxo Group Limited. The JOLIANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
joliant

General Information

Serial Number85679294
Word MarkJOLIANT
Filing DateTuesday, July 17, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 14, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 18, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 24, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, March 14, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 14, 2016ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 8, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 7, 2015EXTENSION 5 GRANTED
Tuesday, June 30, 2015EXTENSION 5 FILED
Tuesday, June 30, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 22, 2015EXTENSION 4 GRANTED
Friday, January 16, 2015EXTENSION 4 FILED
Friday, January 16, 2015TEAS EXTENSION RECEIVED
Saturday, July 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 18, 2014EXTENSION 3 GRANTED
Monday, July 14, 2014EXTENSION 3 FILED
Monday, July 14, 2014TEAS EXTENSION RECEIVED
Friday, February 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2014EXTENSION 2 GRANTED
Monday, February 3, 2014EXTENSION 2 FILED
Monday, February 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 3, 2014TEAS EXTENSION RECEIVED
Friday, August 9, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 7, 2013EXTENSION 1 GRANTED
Wednesday, August 7, 2013EXTENSION 1 FILED
Wednesday, August 7, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 12, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 18, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 18, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 28, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 9, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 8, 2012ASSIGNED TO EXAMINER
Tuesday, July 24, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 20, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

joliant pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological